DexCom, Inc. (DXCM) Q3 2018 Earnings Results

Dexcom Beats on EPS, Stock Up 1.59%

Dexcom's strong EPS performance significantly exceeded expectations, leading to a positive stock reaction with a 1.59% increase. The lack of revenue figures may raise questions among investors, but the substantial EPS beat indicates strong underlying performance. Management's commentary suggests they are focused on maintaining operational efficiency moving forward.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.17	N/A	+382.90%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management conveyed a positive outlook on the company's ability to manage costs effectively. However, they did not provide specific guidance for future quarters.

Management expressed satisfaction with the EPS performance despite not providing revenue figures.

They highlighted ongoing improvements in operational efficiency.

Dexcom Beats on EPS, Stock Up 1.59%

Key numbers

Management commentary

DexCom, Inc.

More earnings this week

Dexcom Beats on EPS, Stock Up 1.59%

Key numbers

Management commentary